Comparison of cisplatin monotherapy and PLADO in the management in children with standard-risk hepatoblastoma in a resource-challenged nation

• Egile Nagusiak: Sandeep Agarwala (Egilea), Vishesh Jain (Egilea), Anjan Dhua (Egilea), Madur Srinivas (Egilea), Prabudh Goel (Egilea), Sameer Bakhshi (Egilea), Venkateswaran K Iyer (Egilea), Rajni Yadav (Egilea), Manisha Jana (Egilea), Priyanka Naranje (Egilea), Veereshwar Bhatnagar (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background : Recent SIOPEL studies have shown cisplatin monotherapy to be equally effective in management of Standard risk Hepatoblastoma (SRHB)as compared to PLADO. Aims and Objectives: To study the chemotherapy, response and outcomes in children with SRHB. Material and Methods: A retrospective stu...